By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Thursday that its first-quarter revenues increased 30 percent, with a particularly strong quarter for its assay sales.

The Austin, Texas-based multiplex diagnostics and research products firm brought in total revenues of $33.3 million for the three-month period ended March 31, compared to $25.6 million for the first quarter of 2009. The firm beat analysts' consensus estimate for revenue of $32.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.